Golden Biotechnology Liabilities 2024

Liabilities Details

Assessing Golden Biotechnology's Liabilities

Golden Biotechnology's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Golden Biotechnology's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Golden Biotechnology's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Golden Biotechnology's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Golden Biotechnology’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Golden Biotechnology stock

What is the level of liabilities of Golden Biotechnology this year?

Golden Biotechnology has a debt balance of 312.11 M TWD this year.

What were the liabilities of Golden Biotechnology compared to the previous year?

The liabilities of Golden Biotechnology have increased by -7.85% dropped compared to the previous year.

What are the consequences of high debt for investors of Golden Biotechnology?

High liabilities can pose a risk for investors of Golden Biotechnology, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Golden Biotechnology?

Low liabilities mean that Golden Biotechnology has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Golden Biotechnology affect the company?

An increase in liabilities of Golden Biotechnology can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Golden Biotechnology affect the company?

A decrease in the liabilities of Golden Biotechnology can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Golden Biotechnology?

Some factors that can influence the liabilities of Golden Biotechnology include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Golden Biotechnology so important for investors?

The liabilities of Golden Biotechnology are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Golden Biotechnology take to modify the liabilities?

To change its liabilities, Golden Biotechnology can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Golden Biotechnology pay?

Over the past 12 months, Golden Biotechnology paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Golden Biotechnology is expected to pay a dividend of 0 TWD.

What is the dividend yield of Golden Biotechnology?

The current dividend yield of Golden Biotechnology is .

When does Golden Biotechnology pay dividends?

Golden Biotechnology pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Golden Biotechnology?

Golden Biotechnology paid dividends every year for the past 0 years.

What is the dividend of Golden Biotechnology?

For the upcoming 12 months, dividends amounting to 0 TWD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Golden Biotechnology located?

Golden Biotechnology is assigned to the 'Health' sector.

Wann musste ich die Aktien von Golden Biotechnology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Golden Biotechnology from 9/13/2024 amounting to 0 TWD, you needed to have the stock in your portfolio before the ex-date on 9/13/2024.

When did Golden Biotechnology pay the last dividend?

The last dividend was paid out on 9/13/2024.

What was the dividend of Golden Biotechnology in the year 2023?

In the year 2023, Golden Biotechnology distributed 0 TWD as dividends.

In which currency does Golden Biotechnology pay out the dividend?

The dividends of Golden Biotechnology are distributed in TWD.